Results
|
|
19241.
|
|
|
|
19242.
|
|
|
|
19243.
|
|
|
|
19244.
|
|
|
|
19245.
|
|
|
|
19246.
|
|
|
|
19247.
|
|
|
|
19248.
|
|
|
|
19249.
|
|
|
|
19250.
|
|
|
|
19251.
|
Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study. [electronic resource] by
- Bennett, J M
- Young, M S
- Liesveld, J L
- Paietta, E
- Miller, K B
- Lazarus, H M
- Marsh, R D
- Friedenberg, W R
- Saba, H T
- Hayes, F A
- Dewald, G W
- Hiddemann, W
- Rowe, J M
Producer: 20010726
In:
American journal of hematology vol. 66
Availability: No items available.
|
|
|
19252.
|
|
|
|
19253.
|
|
|
|
19254.
|
|
|
|
19255.
|
|
|
|
19256.
|
|
|
|
19257.
|
|
|
|
19258.
|
|
|
|
19259.
|
|
|
|
19260.
|
|